Live Breaking News & Updates on Astrazeneca coronavirus vaccine

Stay informed with the latest breaking news from Astrazeneca coronavirus vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Astrazeneca coronavirus vaccine and stay connected to the pulse of your community

Breakfast-20201230-07:15:00

questions in this as yet are, exactly how long the protection will last. it can last at least six months. beyond that we would expect it to last. but it is likely we will need repeated doses over time. we may need to update the vaccine over time as the virus evolves. that's an interesting point. obviously there isa interesting point. obviously there is a new strain which is particularly infectious. but the scientists hope this will work against that. but as the virus mutates over time, what you are saying is it is possible to make changes to the vaccine? yeah, i think the technology make it quite possible to make changes on a more rapid the timeframe than, for example, the technologies were —— we we re example, the technologies were —— we were using for influenza vaccines. some major advances in the technology driven by the extreme

Protection , Questions , Six , Astrazeneca-coronavirus-vaccine , Virus , Doses , Strain , Point , Changes , Technology , Scientists , Saying

Breakfast-20201230-07:20:00

information from? and who is giving you advice? listen to your doctors, listen to the nhs. this vaccine wasn't developed by politicians. it wasn't developed by politicians. it wasn't developed by huge corporations looking to make masses of money out of it. it's in done on a not—for—profit basis and it was done through the nhs, through researchers at oxford university, andl researchers at oxford university, and i believe these are people i felt i could trust. and i would really encourage people, if you want to help out of the nhs, if you are looking at venues and are seeing the stories of hospitals being overwhelmed, then taking up the vaccine is something really constructive people could do that would help the nhs when they really needed. it's ok for other people taking it now, because it has been approved. at the point you had it it was not approved. did you feel nervous? yeah, of course. of course i felt nervous. i am a mum. i got two teenage kids. i've got family who loved me. i didn't want to do anything that would affect my health

Vaccine , Nhs , Mo-ney , It-wasn-t , Politicians , Information , Doctors , Corporations , Masses , People , Oxford , Basis

Breakfast-20201230-07:22:00

wonderful news. and who think there is light at the end of the tunnel. i just listened to your interview with lydia. what an inspiring woman. and what a story. also, i hope that people will listen to what he said about is what we can do to protect the nhs and get control of this virus by getting this vaccine. and due to people like her, but also, she said, the amazing scientists at oxford university and in our nhs, that we can, i hope, look forward to a brighter future after everything we have gone through in this terrible year. a thought then and what might happen regarding restrictions over heres in england? the health secretary is expected to make a statement later. what are you hoping to see? well, the vaccine is on the horizon. and people will start to get that astrazeneca

People , Story , Woman , Interview , The-end-of-tunnel , Lydia-guthrie , Astrazeneca-coronavirus-vaccine , Virus , Nhs , Oxford , Scientists , Control

Breakfast-20201230-07:19:00

you had the vaccine or the placebo? well they used either the covid vaccine or a meningitis a vaccine. none of the snow which one we got. from the side effects i suspect i got the covid vaccine because i had symptoms that were consistent with that. but i won't know for sure until the end of the trial. ok. people would be interested because this is going to be rolled out. we will speak to matt hancock shortly here on bbc. what kind of side effects that you have? here on bbc. what kind of side effects that you have ?|j here on bbc. what kind of side effects that you have? i had a side effects that you have? i had a side effects that you have? i had a side effects that were just like the ones they warned me about. it was like a flu jab might. i would really suggest to anybody who is thinking about taking up the offer of having the vaccine, to make a really careful decision about their health and their welfare. you know, we all think really hard about any kind of medical treatment. and it vaccine is just at the same. but i would really encourage people to be really clear about where are you getting your

Astrazeneca-coronavirus-vaccine , Snow , Vaccine , Covid-19 , Side-effects , Meningitisa-vaccine , None , Placebo , One , People , Kind , Matt-hancock

Breakfast-20201230-07:36:00

everybody, everybody watching, and the whole country. this is a real british success story, a combination of the science at oxford university and the uk and vaccines network, the government funding through the national institutes of health and ri sol—ju have done an absolutely brilliantjob, obviously astrazeneca, and the nhs. so, this isa astrazeneca, and the nhs. so, this is a really good news this morning that the vaccine has not onlyjust been approved but also that they find that the immunity to the disease comes after around a fortnight after the first dose, which means we can really accelerate the number of people who get protected. right, and you talk about accelerating so we know with the previous vaccine people had to have two doses are what will you do here? prioritise the first dose coming out? that's right. the regulator will set out later today the details and the data from the huge clinical trial taking place, along with the

Country , Uk , Vaccines , Everybody , Oxford , Science , Absolutely , Real-british-success-story , Government-funding , Combination , National-institutes-of-health , Ri-sol-ju

Breakfast-20201230-07:33:00

high—risk groups with two vaccines now approved and it goes on to say we'll be able to vaccinate a greater number of people who are at highest risk protecting them from the disease and reducing mortality and hospitalisation. there is so much to know about this because the key to this, one of the things that is key, is that unlike the previous vaccine, the pfizer/biontech vaccine, this doesn't need to be transported at -70 doesn't need to be transported at —70 degrees which will make it much easier to get the vaccine to other parts of the country and be able to speed up the process and roll—out of the vaccine. much cheaper as well, only £3 a dose, the astrazeneca vaccine, which makes it more affordable. astrazeneca said it would be done across the world as a not for profit project so they are supplying it. as fergus walsh said, it is the big hope for the world, more of this vaccine will be used around the globe, that has been ordered. indonesia has ordered 50

People , Risk , Vaccines , Number , Groups , Disease , Hospitalisation , Mortality , Two , Astrazeneca-coronavirus-vaccine , Things , One

Breakfast-20201230-07:35:00

january the 4th. as louise says it is much more transportable so it can be in gp surgeries and as many of you were saying this morning and getting in touch, it can be administered in care homes rather than having to be stored at —70 and having to be administered in hospital. what we want to know is what is the priority? there was a list previously from the joint committee of backs and immunisation about how they would roll the pfizer vaccine. i think we can speak to matt hancock right now. good morning, and i can see by these mothers is a good morning for you. how significant is this? this is a very significant moment in the fight against this pandemic because the vaccine the way out. and the approval of the oxford astrazeneca vaccine brings forward the date at which we will bring this pandemic to an end so it is good news for

Many , Care-homes , Louise-minchin , 4th , Touch , Gp-surgeries , January-the-4th , 4 , Immunisation , Priority , Pfizer , Hospital

Breakfast-20201230-07:13:00

very cold temperature at which it has to be stored. —— pfizer—biontech. this can be kept in a normalfridge. iwill that pfizer—biontech. this can be kept in a normalfridge. i will that help pfizer—biontech. this can be kept in a normal fridge. i will that help to speed up the roll—out? a normal fridge. i will that help to speed up the roll-out? it means that all of the centres that would normally get involved in that stage, and all bdp practices, as well as more simple community for example, can get involved in the vaccine. —— all of the gp practices. we can take the vaccine to where it is needed rather than bring people into the limited places where we can deliver it. so it should make for a step change and it should also reach out to be most affected communities. and although this is a uk designed, uk made vaccine, this really is the one that the world is looking to, because of some of the reasons you have outlined. more of this is being ordered around the world than anywhere else, isn't it?|j ordered around the world than anywhere else, isn't it? i believe so. i think what we need are

Help , Temperature , Fridge , Normalfridge , Pfizer-biontech , Iwill , Astrazeneca-coronavirus-vaccine , Al-l , Example , Community , Stage , Bdp-practices

Breakfast-20201230-07:34:00

million doses of it to work with their population so this is the one which the world is hanging a lot of hope on. and what is really interesting to see as well is the first dose and second dose, is because they are saying everyone will receive a second dose within 12 weeks of the first dose and the second dose completes the course and is important for longer term protection but it means they can get more doses out to more people. it also means as well that the key thing about this vaccine particularly is no one who received at least one dose of the vaccine when they were doing the trial was hospitalised with co—covid—19. as roger is saying, it cost £3 a dose and we will speak to the health secretary shortly. the key is to start rolling it out. obviously they've started with vaccinating people with the pfizer vaccine but this one they are saying and we will talk to matt hancock about this is that it might start as early as

One , Lot , Everyone , Dose , World , Population , Hope-on , 50-million , People , Protection , Doses , Term

Breakfast-20201230-07:40:00

keep to keep the pfizer vaccine at -70 keep to keep the pfizer vaccine at —70 has made it more challenging to get out to smaller care homes and those limitations are not therefore this 0xford astrazeneca vaccine so we can get out and vaccinate people living in care homes who are some of the most vulnerable to this disease so this is another piece of good news. lots of people will be watching and thinking how do i get this vaccine? it is really important that you wait for the nhs to contact you. one of the wonderful things about having the nhs in this country is that they look after everybody. and they will be contacting people in priority order to make sure that, essentially, we save as many lives as possible because we know that this disease targets the most elderly and the most vulnerable, and

Astrazeneca-coronavirus-vaccine , Vaccine , Care-homes , Pfizer , Limitations , 0-s , People , News , Disease , Lots , Nhs , Vulnerable